The CARs demonstrated effective recognition and destruction of tumour cells, as evidenced by a significant loss of NKG2D ligands on the biopsy samples from injected sites, along with necrosis of tumour cells, suggesting that the CAR-NK cells effectively eliminated tumour cells. The gene discussed is KLRK1; the disease is neoplasm.